Canada markets closed

Acorda Therapeutics, Inc. (CDG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
8.420.00 (0.00%)
At close: 03:32PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
115,664
117,633
118,566
129,071
152,967
Cost of Revenue
15,756
15,283
30,332
40,787
33,513
Gross Profit
99,908
102,350
88,234
88,284
119,454
Operating Expenses
Research Development
4,720
5,152
5,804
10,420
23,012
Selling General and Administrative
95,555
89,698
106,256
124,399
152,576
Total Operating Expenses
123,992
125,614
130,270
165,583
206,351
Operating Income or Loss
-24,084
-23,264
-42,036
-77,299
-86,897
Interest Expense
32,337
31,533
30,200
30,035
30,574
Total Other Income/Expenses Net
-248,602
-241,754
35,080
-1,745
8,988
Income Before Tax
-304,440
-296,021
-35,247
-109,074
-107,667
Income Tax Expense
-41,015
-43,167
30,669
-5,120
-8,073
Income from Continuing Operations
-263,425
-252,854
-65,916
-103,954
-99,594
Net Income
-263,425
-252,854
-65,916
-103,954
-99,594
Net Income available to common shareholders
-263,425
-252,854
-65,916
-103,954
-99,594
Basic EPS
2.61
-
-66.80
-195.80
-246.40
Diluted EPS
2.61
-
-66.80
-195.80
-246.40
Basic Average Shares
1,264
-
985.35
531.05
404.2
Diluted Average Shares
1,264
-
985.35
531.05
404.2